Skip to content

Network Oncology - therapy accompanying evaluation of health services research in integrative oncolgy

Network Oncology - therapy accompanying evaluation of health services research in integrative oncolgy - Network Oncology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00013335
Enrollment
14000
Registered
2017-11-27
Start date
2011-02-05
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50 C34 C20 C18 C19 C15 C16 C22 C24 C26 C75

Interventions

Group 1: Epidemiological oncological observational study without intervention for the evaluation of integrative oncological therapy concepts in health services research. All oncological patients ag

Sponsors

Forschungsinstitut Havelhöhe (FIH) gGmbH am Gemeinschaftskrankenhaus Havelhöhe
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Written informed consent. Cancer, see chapter health condition/ disease studies.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Systematic documentation of all oncological therapies under consideration of all treatment remedies and application of integrative therapeutic concepts on the basis of patient files for the illustration of health services research until January, 31st, 2032.

Secondary

MeasureTime frame
Comparative analyses of treatment patterns of applied therapies

Countries

Germany

Contacts

Public ContactAntje Merkle

Forschungsinstitut Havelhöhe (FIH) gGmbH am Gemeinschaftskrankenhaus Havelhöhe

antje.merkle@havelhoehe.de03036501626

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 26, 2026